Javier Aspa

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia.

Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia.

Journal: Clinical chemistry and laboratory medicine
Published: April 18, 2025

The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer.

The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 29, 2024

A genome-wide association study of adults with community-acquired pneumonia.

A genome-wide association study of adults with community-acquired pneumonia.

Journal: Respiratory research
Published: June 11, 2024

Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID.

Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID.

Journal: Clinical immunology (Orlando, Fla.)
Published: April 08, 2024

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Journal: Frontiers in medicine
Published: May 07, 2023

Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.

Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 19, 2022

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.

Journal: Cancers
Published: May 09, 2022

A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.

A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.

Journal: Frontiers in immunology
Published: November 15, 2021

Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia.

Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia.

Journal: PloS one
Published: April 03, 2020

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.

Journal: Oncoimmunology
Published: November 16, 2019

Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.

Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.

Journal: PloS one
Published: February 23, 2019

Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients.

Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 21, 2018
Showing 1-12 of 27

Last Updated: 09/26/2026